DrugDashboards

Xenon

Xenon XE-133 · XENON XE-133 10 mCi/1 · Gas · Respiratory (Inhalation) · Lantheus Medical Imaging, Inc.

NDC 11994-0127-11 · 1 VIAL in 1 CAN / 1 GAS in 1 VIAL · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$353.19
Reported to Texas DSHS · 2026 annual filing · Lantheus Medical Imaging, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$1,873
26 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA017284
TE code
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Xenon XE-133 (Gas)

LabelerStrengthFirst seenLast seen
Lantheus Medical Imaging, Inc.XENON XE-133 10 mCi/1Jul 15, 2026Sep 2, 2026
Lantheus Medical Imaging, Inc.XENON XE-133 20 mCi/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Xenon — NDC 11994-0127-11," retrieved September 3, 2026, https://drugdashboards.com/drug/11994012711.

Free to cite with attribution — see how the data is put together.